A European Multicenter Study of 616 Patients Receiving the Freedom Solo Stentless Bioprosthesis

At 1-year follow-up after Freedom Solo implantation, we found acceptable clinical results with low mortality and morbidity and good hemodynamic performance, confirming safety and effectiveness in this multicenter experience.